Romilkimab (SAR156597) is a chimeric humanized immunoglobulin antibody engineered to specifically target both interleukin-4 (IL-4) and interleukin-13 (IL-13). This dual specificity allows for potential therapeutic applications in treating diseases characterized by overactive IL-4 and IL-13 pathways, such as certain inflammatory and autoimmune disorders.
Romilkimab (SAR156597) is a chimeric humanized immunoglobulin antibody engineered to specifically target both interleukin-4 (IL-4) and interleukin-13 (IL-13). This dual specificity allows for potential therapeutic applications in treating diseases characterized by overactive IL-4 and IL-13 pathways, such as certain inflammatory and autoimmune disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
